TTE Podcast: Advisors, Journals and Antivirals

This time we are discussing a medley of linked topics arising from our latest posts:

Public health officials going native and being economical with the truth,

Cochrane double standards in COI disclosure,

The end of the pandemic

Some of the comments from our Trust the Evidence quiz.

How far we got with our antivirals series and how topical this is.

Enjoy.

The CDC Director Misinformed Congress on Cochrane Review A122.

Tom Jefferson and Carl Heneghan

·

May 9

On the 20th of April, we reported how the CDC Director, Dr Rochelle Walensky, misinformed a hearing of the US House Committee. As a result of the factual error of reporting the summary of the review had been “retracted”, the corresponding and lead authors of the Cochrane Review on

Read full story

The Story of Influenza Antivirals: Part 13

Carl Heneghan and Tom Jefferson

·

May 12

When we started the 2009 update of the review, we received a comment from a Japanese paediatrician, Keiji Hayashi. He pointed out that the data in a Roche-sponsored meta-analysis published by Kaiser and colleagues in a prestigious journal came from ten placebo-controlled trials on various populations. But only two had ever been published; the remaining …

Read full story

How much did we spend on antivirals?

Answered on 11 May 2023

The following table shows the spend for England by financial year for the procurement of antivirals for use during an influenza pandemic. Years not presented are a nil return. See here